Trinity Biotech Ltd
₹
None%
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE -1.66 %
- ROE -136 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
- Company has high debtors of 15,215 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Figures in Rs. Crores
Mar 2006 | Mar 2007 | |
---|---|---|
0.37 | 0.19 | |
0.06 | 0.30 | |
Operating Profit | 0.31 | -0.11 |
OPM % | 83.78% | -57.89% |
0.00 | 0.00 | |
Interest | 0.00 | 0.00 |
Depreciation | 0.07 | 0.06 |
Profit before tax | 0.24 | -0.17 |
Tax % | 0.00% | 0.00% |
0.24 | -0.17 | |
EPS in Rs | 0.72 | -0.51 |
Dividend Payout % | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -49% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -171% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | -136% |
Balance Sheet
Figures in Rs. Crores
Mar 2006 | Mar 2007 | |
---|---|---|
Equity Capital | 3.33 | 3.33 |
Reserves | -3.12 | -3.29 |
9.97 | 10.24 | |
5.07 | 5.69 | |
Total Liabilities | 15.25 | 15.97 |
0.35 | 0.01 | |
CWIP | 0.00 | 0.00 |
Investments | 2.12 | 2.06 |
12.78 | 13.90 | |
Total Assets | 15.25 | 15.97 |
Cash Flows
Figures in Rs. Crores
Mar 2006 | Mar 2007 | |
---|---|---|
-0.62 | ||
0.36 | ||
0.27 | ||
Net Cash Flow | 0.01 |
Ratios
Figures in Rs. Crores
Mar 2006 | Mar 2007 | |
---|---|---|
Debtor Days | 7,063.24 | 15,214.74 |
Inventory Days | ||
Days Payable | ||
Cash Conversion Cycle | 7,063.24 | 15,214.74 |
Working Capital Days | 7,586.08 | 15,714.21 |
ROCE % | -1.66% |
Documents
Announcements
No data available.
Annual reports
No data available.